A possible structural determinant of selectivity of boldine and derivatives for the (xlA-adrenoceptor subtype
1 The selectivity of action of boldine and the related aporphine alkaloids, predicentrine (9-0- methylboldine) and glaucine (2,9-0-dimethylboldine) on oel-adrenoceptor subtypes was studied by examining [3H]-prazosin competition binding in rat cerebral cortex. WB 4101 and benoxathian were used as selective CXA-adrenoceptor antagonists. 2 In the competition experiments [3H]-prazosin (0.2 nM) binding was inhibited by WB 4101 and benoxathian. The inhibition curves displayed shallow slopes which could be subdivided into high and low affinity components (pKi=9.92 and 8.29 for WB 4101, 9.35 and 7.94 for benoxathian). The two antagonists recognized approximately 37% of the sites with high affinity from among the total [3H]- prazosin specific binding sites. 3 Boldine, predicentrine and glaucine also competed for [3H]-prazosin (0.2 nM) binding with shallow and biphasic curves recognizing 30-40% of the sites with high affinity. Drug affinities (pKi) at the high and low affinity sites were, 8.31 and 6.50, respectively, for boldine, 8.13 and 6.39 for predicentrine, and 7.12 and 5.92 for glaucine. The relative order of selectivity for aA-adrenoceptors was boldine (70 fold aIA-selective)=predicentrine (60 fold, xA-selective) > glaucine (15 fold, xA-selective). 4 Pretreatment of rat cerebral cortex membranes with chloroethylclonidine (CEC, 10 pM) for 30 min at 37°C followed by thorough washing out reduced specific [3H]-prazosin binding by approximately 70%. The CEC-insensitive [3H]-prazosin binding was inhibited by boldine monophasically (Hill slope= 0.93) with a single pKi value (7.76). 5 These results suggest that whereas the aporphine structure shared by these alkaloids is responsible for their selectivity of action for the aIA-adrenoceptor subtype in rat cerebral cortex, defined functional groups, namely the 2-hydroxy function, induces a significant increase in aCIA-subtype selectivity and affinity.
Supported by a research grant from the Spanish Comisi6n Interministerial de Ciencia y Tecnologia (SAF95-0538).
Quote ItemBritish Journal of Pharmacology, Vol. 119, p. 1563-1568, 1996.